Uncategorised - European Medical Journal

Man in hospital bed

Mas30 Liver Grafts Linked to Lower Survival in MASLD Transplants

Mas30 liver grafts were associated with lower graft survival in MASLD recipients, a pattern not seen in metALD or ALD.

close up of canccer vaccine for pancreatic cancer

New Pancreatic Cancer Vaccine Shows Promise in Prevention

Targeting pancreatic precursor lesions through a mutant KRAS vaccine generated durable immune responses for long-term cancer interception.

kratom drug, kratom plant, kratom pills

Kratom Toxicity Linked to Surge in Severe Neurological Complications

Kratom toxicity cases have surged nationwide over the decade, triggering severe clinical complications and acute hospitalizations.

Urological cancers

AI in Urological Cancer Imaging Shows Strong Diagnostic Performance

AI in urological cancer diagnosis showed strong imaging performance, with higher pooled specificity and AUC than clinicians. Find out more.

EULAR 2026 Interview: Wilson Bautista-Molano

One of the most relevant aspects of EULAR 2026 was the continued move towards more personalised, data-driven rheumatology for inflammatory…

Spanish Society of Allergology and Clinical Immunology (SEAIC)

The Spanish Society of Allergology and Clinical Immunology (SEAIC) continues to strengthen its position as one of Spain’s most dynamic…

Novel Therapeutics and Antifungal Agents

The growing incidence of invasive fungal infections, coupled with the escalating antifungal resistance, has heightened the demand…

Gloved hands prepare blood transfusion.

NHS Rolls Out Programme to Reduce Kidney Transplant Rejection

New NHS double-match blood transfusion programme aims to reduce kidney transplant rejection and save up to 100 transplanted kidneys a year.

Cerebral Small Vessel Disease Burden Links to Kidney Dysfunction

Greater MRI defined cerebral small vessel disease burden was associated with poorer kidney function and albuminuria in older adults, with hypertension potentially accounting for part of the relationship.

Oncologist reviewing treatment options including atezolizumab for extensive-stage small cell lung cancer.

Atezolizumab Lowers Extensive-Stage Small Cell Lung Cancer Costs

Atezolizumab lowered monthly medical costs while delivering similar survival to durvalumab in extensive-stage small cell lung cancer.